The Wall Street Journal reached out to addiction expert, Dr. Cidambi to get her views on “Flakka,” a synthetic stimulant. She explains Flakka’s effects on the body and the mind.
Television station WWOR solicited addiction expert, Dr. Cidambi’s opinion on Probuphine, an implantable form of buprenorphine, recently approved by the FDA. Probuphine is recommended for maintenance treatment of dependence on opiates. It is to be used to address opiate cravings and opiate withdrawal.
1. Outpatient Rehab Offers Another Option for Addicts. NJTVonline.org
2. Dr. Cidambi discusses addiction to alcohol and drugs with the mothers of TAM (The Addict’s Mom). How to identify if a loved is addicted? How to take steps to get them into treatment?
Gary Jacobs, Chief Editor of Long Island Backstory interviews Dr. Cidambi: Advantages of the Ambulatory Detox model relative to Traditional models. Mr. Jacobs acknowledges the pioneering effort of Dr. Cidambi to drive towards a lower cost, higher efficacy model to treat addiction.
RT America, an arm of Russia’s largest TV station, asked addiction expert, Dr. Cidambi to comment on the sharp price increases in Naloxone, the opioid overdose reversal drug. Naloxone is a life saving drug and sharp price increases could limit use and sacrifice lives to opiate overdose.